Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.67 USD | -0.27% |
|
-1.31% | +13.15% |
30/05 | Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics | CI |
28/05 | Anika Therapeutics Approves $40 Million Share Repurchase Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.15% | 38Cr | |
+2.87% | 9.42TCr | |
-4.08% | 3.78TCr | |
-13.97% | 3.25TCr | |
+73.38% | 2.78TCr | |
-11.99% | 1.61TCr | |
-1.78% | 1.42TCr | |
-11.67% | 1.14TCr | |
+190.36% | 1.11TCr | |
-52.61% | 908.81Cr |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $40.5M, vs. Street Est of $39.1M